APA

Dulucq S., Etienne G., Morisset S., Klein E., Chollet C., Robbesyn F., Turcq B., Tigaud I., Hayette S., Nicolini F. E. & Mahon F. (20190425). Impact of second decline rate of BCR-ABL1 transcript on clinical outcome of chronic phase chronic myeloid leukemia patients on imatinib first-line. : Annals of hematology.

Chicago

Dulucq Stephanie, Etienne Gabriel, Morisset Stephane, Klein Emilie, Chollet Claudine, Robbesyn Fanny, Turcq Beatrice, Tigaud Isabelle, Hayette Sandrine, Nicolini Franck E and Mahon François-Xavier. 20190425. Impact of second decline rate of BCR-ABL1 transcript on clinical outcome of chronic phase chronic myeloid leukemia patients on imatinib first-line. : Annals of hematology.

Harvard

Dulucq S., Etienne G., Morisset S., Klein E., Chollet C., Robbesyn F., Turcq B., Tigaud I., Hayette S., Nicolini F. E. and Mahon F. (20190425). Impact of second decline rate of BCR-ABL1 transcript on clinical outcome of chronic phase chronic myeloid leukemia patients on imatinib first-line. : Annals of hematology.

MLA

Dulucq Stephanie, Etienne Gabriel, Morisset Stephane, Klein Emilie, Chollet Claudine, Robbesyn Fanny, Turcq Beatrice, Tigaud Isabelle, Hayette Sandrine, Nicolini Franck E and Mahon François-Xavier. Impact of second decline rate of BCR-ABL1 transcript on clinical outcome of chronic phase chronic myeloid leukemia patients on imatinib first-line. : Annals of hematology. 20190425.